Abstract: Multimodal fusion is an effective solution for holistic brain tumor diagnosis; however, it faces challenges under missing modalities. Traditional multi-encoder architectures can easily ...

Abstract: Precise tumor localization and sub-region identification are critical for disease diagnosis. However, current Weakly Supervised Semantic Segmentation (WSSS) methods for brain tumor ...

Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology. However, technological ...

Add Yahoo as a preferred source to see more of our stories on Google. BrainIAC, a new AI model, analyzes brain MRIs to predict dementia risk, tumor mutations, and brain cancer survival. (CREDIT: ...

Share on Pinterest A new AI tool may help predict disease risk using brain MRI datasets. Image credit: Tunvarat Pruksachat/Getty Images The wellness of the brain plays an important role in living a ...

The human brain is complex. Artificial intelligence (AI) machine learning and medical imaging data are accelerating breakthroughs in brain health, especially in medical diagnostics. A peer-reviewed ...

A potential breakthrough in the fight against glioblastoma, the deadliest form of brain cancer, is emerging from UVA Cancer Center. University of Virginia scientists, with support from the National ...

As shown below, the inferred masks predicted by our segmentation model trained by the dataset appear similar to the ground truth masks. This repository contains a curated and enhanced version of brain ...

The FDA halted studies of two investigational gene therapies for rare pediatric diseases after a child treated in a clinical trial developed a brain tumor, RegenxBio said Wednesday. The holds affect ...

A central nervous system (CNS) tumor has prompted the FDA to place clinical holds on two Regenxbio gene therapies, including a candidate that is less than two weeks away from an approval decision.